PNT - POINT Biopharma Global GAAP EPS of -$0.26 beats by $0.01 November, 14 2022 09:22 AM POINT Biopharma Global Inc. POINT Biopharma Global press release ( NASDAQ: PNT ): Q3 GAAP EPS of -$0.26 beats by $0.01 . Cash, Cash Equivalents and Investments as of September 30, 2022, $291.5 million For further details see: POINT Biopharma Global GAAP EPS of -$0.26 beats by $0.01